Stempeutics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 47

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $6.4M

  • Investors
  • 5

Stempeutics General Information

Description

Developer of a stem-cell platform designed to develop and commercialize novel therapeutics based on adult stem cells. The company's platform builds an IP portfolio and is proactively engaged in extensive research in the area of stem cell technology and its application, enabling healthcare professionals to have stem cell products that address the major unmet medical needs of a patient.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • 3rd Floor, Manipal Hospitals Whitefield Number 143
  • EPIP Industrial Area, ITPL Main Road, Whitefield
  • Bangalore, Karnataka 560048
  • India
+91 080 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stempeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 07-Sep-2022 $6.4M 000.00 000.00 Completed Generating Revenue
8. Later Stage VC 24-Jul-2019 00.000 0000 000.00 Completed Generating Revenue
7. Later Stage VC 04-Jul-2016 00.000 000.00 000.00 Completed Generating Revenue
6. Merger/Acquisition 15-Oct-2015 Cancelled Generating Revenue
5. Later Stage VC 09-Mar-2015 00.000 000.00 0000 Completed Generating Revenue
4. Later Stage VC 10-Jul-2014 00.000 0000 000.00 Completed Generating Revenue
3. Grant 11-Nov-2011 00000 0000 Completed Generating Revenue
2. Early Stage VC 01-Jun-2009 $10M $10M 000.00 Completed Startup
1. Joint Venture Completed Startup
To view Stempeutics’s complete valuation and funding history, request access »

Stempeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Stempeutics’s complete cap table history, request access »

Stempeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a stem-cell platform designed to develop and commercialize novel therapeutics based on adult stem cells. Th
Drug Discovery
Bangalore, India
47 As of 2023
000.00
000.00 0000-00-00
0000000000 0 000.00

000000

d do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
0000 000000000
Bengaluru, India
00 As of 0000
000.00
000.00 0000-00-00
00000000000 000.00

000000

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incidi
0000000000000
Navi Mumbai, India
00 As of 0000
000.00
00000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Stempeutics Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immuneel Venture Capital-Backed Bengaluru, India 00 000.00 00000000000 000.00
ImmunoACT Venture Capital-Backed Navi Mumbai, India 00 000.00 00000 00000
Bugworks Research Venture Capital-Backed Saratoga, CA 00 000.00 00000000000 000.00
Biocon Formerly PE-Backed Bengaluru, India 00000 000.00 00000000 000.00
To view Stempeutics’s complete competitors history, request access »

Stempeutics Patents

Stempeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240189359-A1 Combination therapy comprising a composition of mesenchymal stromal cells and hyaluronic acid for use in treatment of osteoarthritis Pending 07-Dec-2022 000000000
CA-2878299-A1 Methods of upscaling mesenchymal stromal cell production, compositions and kit thereof Inactive 24-Jun-2014 0000000000
JP-2016007214-A Method to scale up mesenchymal interstitial cell production, composition thereof and a kit Pending 24-Jun-2014 0000000000 0
EP-2960329-A1 Methods of upscaling mesenchymal stromal cell production, compositions and kit thereof Inactive 24-Jun-2014 0000000000 0
US-20170100434-A1 Management of ischemia using pooled mesenchymal stromal cell composition Active 26-Mar-2014 A61K35/28
To view Stempeutics’s complete patent history, request access »

Stempeutics Executive Team (5)

Name Title Board Seat Contact Info
Balu Manohar Chief Executive Officer, Managing Director & Board Member
Trina Bawari Head of Finance & Corporate Affairs
Ranjan Pai MD Founder
You’re viewing 3 of 5 executive team members. Get the full list »

Stempeutics Board Members (9)

Name Representing Role Since
Anurag Bagaria Kemwell Biopharma Board Member 000 0000
Chandru Chawla Cipla New Ventures Board Member 000 0000
Hebri Ballal Self Board Member 000 0000
Jaideep Gogtay MD Cipla Board Member 000 0000
Ramkumar Mandalam Ph.D Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Stempeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stempeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kemwell Biopharma Corporation Minority 000 0000 000000 0
Department of Biotechnology Government 000 0000 000000 0
Cipla New Ventures Impact Investing Minority 000 0000 000000 0
Cipla Corporation Majority 000 0000 000000 0
Manipal Education and Medical Group Corporation Majority 000 0000 000000 0
To view Stempeutics’s complete investors history, request access »

Stempeutics FAQs

  • When was Stempeutics founded?

    Stempeutics was founded in 2006.

  • Who is the founder of Stempeutics?

    Ranjan Pai MD is the founder of Stempeutics.

  • Who is the CEO of Stempeutics?

    Balu Manohar is the CEO of Stempeutics.

  • Where is Stempeutics headquartered?

    Stempeutics is headquartered in Bangalore, India.

  • What is the size of Stempeutics?

    Stempeutics has 47 total employees.

  • What industry is Stempeutics in?

    Stempeutics’s primary industry is Drug Discovery.

  • Is Stempeutics a private or public company?

    Stempeutics is a Private company.

  • What is the current valuation of Stempeutics?

    The current valuation of Stempeutics is 000.00.

  • What is Stempeutics’s current revenue?

    The current revenue for Stempeutics is 000000.

  • How much funding has Stempeutics raised over time?

    Stempeutics has raised $33.4M.

  • Who are Stempeutics’s investors?

    Kemwell Biopharma, Department of Biotechnology, Cipla New Ventures, Cipla, and Manipal Education and Medical Group have invested in Stempeutics.

  • Who are Stempeutics’s competitors?

    Immuneel, ImmunoACT, Bugworks Research, and Biocon are competitors of Stempeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »